Skip to content

Cannabis: all studies

Page 131 of 288: studies 1,301 to 1,310 of 2,874, newest first. Back to the cannabis overview

Research

The effect of cannabis use on memory function: an update.

Substance Abuse and Rehabilitation 2013 Tabea Schoeler, Sagnik Bhattacharyya

Investigating the effects of cannabis use on memory function appears challenging. While early observational investigations aimed to elucidate the longer-term effects of cannabis use on memory function in humans, findings remained equivocal and pointed to a pattern of interacting factors impacting on the relationship between cannabis use and memory function, rather than a simple direct effect of...

Investigating common risk factors in the comorbidity of cannabis use and psychosis

eScholarship@McGill 2013 Clifford M. Cassidy

Introduction. La comorbidité entre les troubles psychotiques et l'abus de substances est associée à une évolution négative. Pour mieux traiter l'abus de substance dans la psychose, il est nécessaire d'identifier les facteurs spécifiques qui augmentent la prévalence de consommation de substances dans cette population, particulièrement les aspects du trouble psychotique qui pourraient exacerber...

Cannabis Use during Adolescent Development: Susceptibility to Psychiatric Illness

Frontiers in Psychiatry 2013 Benjamin J. Chadwick, M. L. Miller, Yasmin L. Hurd 216 citations

Cannabis use is increasingly pervasive among adolescents today, even more common than cigarette smoking. The evolving policy surrounding the legalization of cannabis reaffirms the need to understand the relationship between cannabis exposure early in life and psychiatric illnesses. cannabis contains psychoactive components, notably Δ(9)-tetrahydrocannabinol (THC), that interfere with the...

Pathways from Cannabis to Psychosis: A Review of the Evidence

Frontiers in Psychiatry 2013 Jonathan Kenneth Burns 63 citations

The nature of the relationship between cannabis use (CU) and psychosis is complex and remains unclear. Researchers and clinicians remain divided regarding key issues such as whether or not cannabis is an independent cause of psychosis and schizophrenia. This paper reviews the field in detail, examining questions of causality, the neurobiological basis for such causality and for differential...

Amygdala activity contributes to the dissociative effect of cannabis on pain perception

Pain 2013 Michael Lee, M. Ploner, K. Wiech et al.

Summary fMRI evidence suggests that delta‐9‐tetrahydrocannabinol, the psychoactive component of cannabis, targets the affective aspects of pain in humans by altering the activity and functional connections of the amygdala. Abstract Cannabis is reported to be remarkably effective for the relief of otherwise intractable pain. However, the bases for pain relief afforded by this psychotropic agent...

Cannabis use and vulnerability for psychosis in early adolescence—a TRAILS study

Addiction December 10, 2012 Merel F. H. Griffith‐Lendering, Johanna T. W. Wigman, Andrea Prince van Leeuwen et al. 67 citations

AIMS: To examine the direction of the longitudinal association between vulnerability for psychosis and cannabis use throughout adolescence. DESIGN: Cross-lagged path analysis was used to identify the temporal order of vulnerability for psychosis and cannabis use, while controlling for gender, family psychopathology, alcohol use and tobacco use. SETTING: A large prospective population study of...

Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome

Psychological Medicine December 1, 2012 Andrea M. Auther, Danielle McLaughlin, Ricardo E Carrión et al.

Background: Clinical and epidemiological studies suggest an association between cannabis use and psychosis but this relationship remains controversial. Method: Clinical high-risk (CHR) subjects (age 12–22 years) with attenuated positive symptoms of psychosis (CHR+,n=101) were compared to healthy controls (HC,n=59) on rates of substance use, including cannabis. CHR+ subjects with and without...

Inhalation exposure to smoke from synthetic "marijuana" produces potent cannabimimetic effects in mice.

Drug and Alcohol Dependence December 1, 2012 Jason M Wiebelhaus, Justin L. Poklis, Alphonse Poklis et al.

Use of synthetic "marijuana" has increased in recent years, produced adverse effects and prompted the temporary DEA ban of five specific cannabinoid analogs, including JWH-018. The objectives of the current study include determining the chemical content of the herbal product, Buzz, assessing its behavioral effects upon inhalation exposure to mice, determining whether CB(1) receptors mediate its...

Acute Effects of THC on Time Perception in Frequent and Infrequent Cannabis Users

Psychopharmacology November 24, 2012 Richard A Sewell, Ashley Schnakenberg, Jacqueline Elander et al.

Cannabinoids have been shown to alter time perception, but existing literature has several limitations. Few studies have included both time estimation and production tasks, few control for subvocal counting, most had small sample sizes, some did not record subjects’ cannabis use, many tested only one dose, and used either oral or inhaled administration of Δ9-tetrahydrocannabinol (THC), leading...

Manipulating brain connectivity with δ⁹-tetrahydrocannabinol: a pharmacological resting state FMRI study.

Neuroimage November 15, 2012 Linda E. Klumpers, David M. Cole, Najmeh Khalili-Mahani et al.

Resting state-functional magnetic resonance imaging (RS-FMRI) is a neuroimaging technique that allows repeated assessments of functional connectivity in resting state. While task-related FMRI is limited to indirectly measured drug effects in areas affected by the task, resting state can show direct CNS effects across all brain networks. Hence, RS-FMRI could be an objective measure for compounds...